These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37592151)

  • 21. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
    Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
    Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M; Zhai X; Chen Y; Yin D
    Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unraveling the independent role of METTL3 in m6A modification and tumor progression in esophageal squamous cell carcinoma.
    Du B; Wang P; Wei L; Qin K; Pei Z; Zheng J; Wang J
    Sci Rep; 2024 Jul; 14(1):15398. PubMed ID: 38965238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propofol attenuates prostate cancer progression by upregulating TRHDE-AS1 expression, and METTL14 could mediate its m6A modification.
    Chen Z; Li Q; Li Z; Hu G
    Clin Exp Pharmacol Physiol; 2024 Nov; 51(11):e13924. PubMed ID: 39322401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
    He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
    Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA LINC01606 protects colon cancer cells from ferroptotic cell death and promotes stemness by SCD1-Wnt/β-catenin-TFE3 feedback loop signalling.
    Luo Y; Huang S; Wei J; Zhou H; Wang W; Yang J; Deng Q; Wang H; Fu Z
    Clin Transl Med; 2022 Apr; 12(4):e752. PubMed ID: 35485210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m
    Li L; Tang Q; Ge J; Wang D; Mo Y; Zhang Y; Wang Y; Xiong F; Yan Q; Liao Q; Guo C; Wang F; Zhou M; Xiang B; Zeng Z; Shi L; Chen P; Xiong W
    Clin Transl Med; 2024 Jul; 14(7):e1766. PubMed ID: 39021049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CHOP regulated by METTL14-m6A affects cell cycle arrest and regorafenib sensitivity in HCC cells.
    Pan Y; You B; Zhao X; Zhang S; Li W
    BMC Cancer; 2024 Apr; 24(1):525. PubMed ID: 38664644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
    J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.
    Li F; Zhao J; Wang L; Chi Y; Huang X; Liu W
    Mol Biotechnol; 2022 Feb; 64(2):199-212. PubMed ID: 34586620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCF4 and HuR mediated-METTL14 suppresses dissemination of colorectal cancer via N6-methyladenosine-dependent silencing of ARRDC4.
    Wang H; Wei W; Zhang ZY; Liu Y; Shi B; Zhong W; Zhang HS; Fang X; Sun CL; Wang JB; Liu LX
    Cell Death Dis; 2021 Dec; 13(1):3. PubMed ID: 34916487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YTHDF3-mediated m6A modification of NKD1 regulates hepatocellular carcinoma invasion and metastasis by activating the WNT/β-catenin signaling axis.
    Chen S; Wang L; Xu Z; Chen L; Li Q; Zhong F; Tang N; Song J; Zhou R
    Exp Cell Res; 2024 Sep; 442(1):114192. PubMed ID: 39127439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
    Hu N; Ji H
    Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of METTL3 and METTL14 in hepatocellular carcinoma.
    Liu X; Qin J; Gao T; Li C; Chen X; Zeng K; Xu M; He B; Pan B; Xu X; Pan Y; Sun H; Xu T; Wang S
    Aging (Albany NY); 2020 Nov; 12(21):21638-21659. PubMed ID: 33159022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer.
    Huang J; Zhou W; Hao C; He Q; Tu X
    PLoS Genet; 2022 Oct; 18(10):e1010366. PubMed ID: 36288387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRMT1 methylates METTL14 to modulate its oncogenic function.
    Wang J; Wang Z; Inuzuka H; Wei W; Liu J
    Neoplasia; 2023 Aug; 42():100912. PubMed ID: 37269817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased m6A RNA methylation and METTL3 expression may contribute to the synovitis progression of rheumatoid arthritis.
    Su Y; Wu Z; Liu Y; Liu X; Kang J; Jia J; Zhang L
    Exp Cell Res; 2024 Oct; 442(2):114237. PubMed ID: 39245197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer.
    Choi S; Yoo YJ; Kim H; Lee H; Chung H; Nam MH; Moon JY; Lee HS; Yoon S; Kim WY
    Biochem Biophys Res Commun; 2019 Oct; 519(1):100-105. PubMed ID: 31481234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.